Skip to main content

Table 5 Therapy of 174 renal transplant recipients with mucormycosis

From: Mucormycosis in renal transplant recipients: review of 174 reported cases

Therapy Patient number Survived/total number
Amphotericin B formulation
 Deoxycholate 78/174(44.8%) 37/78(47.4%)
 Lipid 64/174(36.8%) 47/64(73.4%)
Posaconazole 13/174(7.5%) 12/13(92.3%)
Itraconazole, voriconazole, fluconazole, encanocandins, and no antifungal therapy 19/174(11.0%) 4/19(21.1%)
Surgery alone 11/174(6.3%) 4/11(36.4%)
Surgery and antifungal therapy 121/174(69.5%) 85/121(70.2%)
Antifungal alone 34/174(19.5%) 11/34(32.4%)
None 8/174(4.6%) 0/8(0%)